Explore more publications!

Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

Press releases published on November 13, 2025

ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
4TEEN4 Extends Series C Financing Round to €55 Million, Supporting Expanded Clinical Development of Procizumab in Cardiogenic Shock
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
شركة Profound Medical توقع اتفاقية توزيع حصرية لمنتجات TULSA-PRO®وSonalleve® مع شركة Al Faisaliah Medical Systems في المملكة العربية السعودية
Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.
IMU Biosciences announces formation of Scientific Advisory Board
Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
Enterome to present positive interim Phase 2 data for lead OncoMimics™ immunotherapy EO2463 in follicular lymphoma at American Society for Hematology (ASH) meeting
T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
Oral Surgery Expert Dr. Yadira Cardona-Rohena Offers Advice on Tooth Extraction Prevention in HelloNation Magazine
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions